TrialJAMA dermatology2023

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).

Eric L Simpson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.